LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Revvity Inc

Closed

SectorHealthcare

93.19 3.22

Overview

Share price change

24h

Current

Min

92.28

Max

93.19

Key metrics

By Trading Economics

Income

-52M

42M

Sales

-65M

665M

P/E

Sector Avg

40.465

56.602

EPS

1.01

Dividend yield

0.28

Profit margin

6.354

Employees

11,000

EBITDA

-151M

72M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+26.61% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.28%

2.45%

Next Earnings

28 lip 2025

Next Dividend date

8 sie 2025

Next Ex Dividend date

18 lip 2025

Market Stats

By TradingEconomics

Market Cap

-2.5B

12B

Previous open

89.97

Previous close

93.19

News Sentiment

By Acuity

34%

66%

86 / 382 Ranking in Healthcare

Revvity Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

18 maj 2025, 23:47 UTC

Market Talk

Nikkei May Trade Rangebound Amid Uncertainty Over U.S. Tariffs -- Market Talk

18 maj 2025, 23:40 UTC

Market Talk

Gold Rises Amid Concerns Over U.S. Fiscal Deficit -- Market Talk

18 maj 2025, 18:00 UTC

Earnings

Tax Bill News; Target, Home Depot, and Snowflake Earnings; and More Stock Market News to Watch This Week -- Barrons.com

18 maj 2025, 17:01 UTC

Top News

GM Is Fighting California on EVs. This Is What It Wants to Overturn and Why. -- Barrons.com

18 maj 2025, 16:20 UTC

Earnings

Tesla Demand Hasn't Rebounded Yet. Watch China This Week. -- Barrons.com

18 maj 2025, 12:09 UTC

Top News

Trump Sounds Upbeat on Ukraine Cease-Fire as Russia Unleashes Drone Barrage -- WSJ

17 maj 2025, 17:15 UTC

Top News

Trump Attacks Walmart for Tariff-Related Price Increases -- WSJ

17 maj 2025, 09:30 UTC

Top News
Earnings

In a Trade War, Walmart Lacks Some of Amazon's Ammunition -- Heard on the Street -- WSJ

17 maj 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 maj 2025, 08:20 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

16 maj 2025, 23:18 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

16 maj 2025, 22:30 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- Update

16 maj 2025, 21:56 UTC

Market Talk

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

16 maj 2025, 21:56 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 maj 2025, 21:54 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- WSJ

16 maj 2025, 21:22 UTC

Market Talk

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

16 maj 2025, 21:17 UTC

Market Talk

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

16 maj 2025, 21:17 UTC

Top News

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

16 maj 2025, 21:05 UTC

Market Talk

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

16 maj 2025, 20:55 UTC

Acquisitions, Mergers, Takeovers

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 maj 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

16 maj 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 maj 2025, 20:37 UTC

Top News

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

16 maj 2025, 20:33 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

16 maj 2025, 20:30 UTC

Acquisitions, Mergers, Takeovers

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

16 maj 2025, 20:18 UTC

Top News

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

16 maj 2025, 20:16 UTC

Top News

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

16 maj 2025, 20:15 UTC

Earnings

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

16 maj 2025, 20:11 UTC

Acquisitions, Mergers, Takeovers

Henry Schein: William K. Daniel Joins Board

16 maj 2025, 20:10 UTC

Acquisitions, Mergers, Takeovers

Henry Schein: Strategic Investment by KKR Completed

Peer Comparison

Price change

Revvity Inc Forecast

Price Target

By TipRanks

26.61% upside

12 Months Forecast

Average 118.08 USD  26.61%

High 135 USD

Low 100 USD

Based on 14 Wall Street analysts offering 12 month price targets forRevvity Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

14 ratings

9

Buy

5

Hold

0

Sell

Sentiment

By Acuity

86 / 382 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.